HT
SLDB icon

HAP Trading’s Solid Biosciences SLDB Stock Holding History

HAP Trading’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-673
Closed -$1K – 2039
2022
Q2 		$1K Buy
+673
New +$6.99K ﹤0.01% 1859
2021
Q3 		– Sell
-1,780
Closed -$1K – 2730
2021
Q2 		$1K Sell
1,780
-387
-18% -$25.6K ﹤0.01% 2289
2021
Q1 		$31K Buy
2,167
+967
+81% +$107K ﹤0.01% 1312
2020
Q4 		$55K Buy
+1,200
New +$75.9K ﹤0.01% 1375
2020
Q1 		– Sell
-1,853
Closed -$2K – 1500
2019
Q4 		$2K Buy
+1,853
New +$204K ﹤0.01% 1172

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return